How We Mark Time and How Time Marks Us
Dr. Gotlib discusses the road to approval of midostaurin for the treatment of advanced systemic mastocytosis.
A Randomized Trial in a Rare Cancer: Targeting CD30 in Cutaneous T Cell Lymphoma Yields Therapeutic Dividends
Dr. Roberts discusses a trial that looks at new therapies to be tested for the treatment of a rare cancer, cutaneous T cell lymphoma.
Download issue as PDF
Dr. Lollar reviews a study that used a gene-trapping strategy4 to identify and characterize flippase function in mammalian cells.
Dr. Gotlib reviews a multicenter collaboration that uncovered the genetic mechanism protecting Tibetan highlanders from polycythemia.
Dr. Vercellotti reviews a study demonstrating that FXIII is critical for RBC retention within clots, with implications for preventing or limiting the extent of venous thrombosis.
Drs. Huang and Becker review a study suggesting that replication stress contributes to the chromosomal damage and functional decline characteristic of old HSCs.
Drs. Nemecek and Kurre examine the role stem-cell transplantation plays in early treatment of inherited immunodeficiencies.
Dr. Coetzer views how epigenetic therapy might be applied to eliminate malaria and serve G6PD-Deficient Patients.
Dr. Koury looks at the role of heme-regulated differentiation on monocytes and macrophages in hemolsysis, iron metabolism, and macrophage differentiation.
Drs. Jonathan Roberts, Robert Montgomery, and Gilbert C. White review recent progress in diagnosing and managing von Willebrand Disease.
Dr. Telen examines the use of ABO and RhD genotyping in transfusion medicine.
Dr. Garcia examines the usefulness of new oral anticoagulants.
Dr. Quinn looks into the effectiveness of anti-adhesive therapy for sickle cell disease.
Dr. Shurin talks about her start in hematology.
Dr. Burns recaps the first lymphoma biology meeting.
Dr. Alexis Thompson makes a thorough assessment of the latest clinical practice guidelines for sickle cell disease.
Dr. Parker wraps up his three-year term as Editor-in-Chief of The Hematologist and welcomes Jason Gotlib, MD, as he assumes the Editor-in-Chief role (2015 to 2017).
September-October 2017Volume 14, Issue 5
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology